Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline
暂无分享,去创建一个
T. Karlsen | C. Hassan | C. Ponsioen | M. Färkkilä | A. Laghi | G. Hirschfield | S. Pereira | J. Poley | J. Dumonceau | A. Tringali | O. Chazouilleres | M. Marzioni | C. Schramm | L. Aabakken | J. Pohl | F. Swahn | P. Fickert | M. Arvanitakis | Michaël Fernandez | J. Albert
[1] M. Manns,et al. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis. , 2017, Gastroenterology.
[2] T. Karlsen,et al. Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease. , 2016, Gastroenterology.
[3] M. Färkkilä,et al. Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia , 2016, Endoscopy.
[4] C. Fuentes-Orozco,et al. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial , 2015, BMC Gastroenterology.
[5] Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. , 2015, Journal of hepatology.
[6] K. Lindor,et al. ACG Clinical Guideline: Primary Sclerosing Cholangitis , 2015, The American Journal of Gastroenterology.
[7] Wei Huang,et al. Rectal indomethacin for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trials. , 2015, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.
[8] A. Bergquist,et al. Prospective evaluation of the clinical utility of single-operator peroral cholangioscopy in patients with primary sclerosing cholangitis , 2015, Endoscopy.
[9] D. Nicolás-Pérez,et al. Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Cost-effectiveness Analysis , 2015, Pancreas.
[10] Kevin E. Woods,et al. Triple modality testing by endoscopic retrograde cholangiopancreatography for the diagnosis of cholangiocarcinoma , 2015, Therapeutic advances in gastroenterology.
[11] U. Navaneethan,et al. ERCP-related adverse events in patients with primary sclerosing cholangitis. , 2015, Gastrointestinal endoscopy.
[12] A. Bergquist,et al. Primary sclerosing cholangitis increases the risk for pancreatitis after endoscopic retrograde cholangiopancreatography , 2015, Liver international : official journal of the International Association for the Study of the Liver.
[13] C. Hassan,et al. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Updated June 2014 , 2014, Endoscopy.
[14] U. Navaneethan,et al. Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. , 2014, Gastrointestinal endoscopy.
[15] B. Han,et al. Rectal NSAIDs for the prevention of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. , 2014, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.
[16] U. Navaneethan,et al. Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. , 2014, Gastrointestinal endoscopy.
[17] E. Sinakos,et al. Update on inflammatory bowel disease in patients with primary sclerosing cholangitis. , 2014, World journal of hepatology.
[18] Maria Pellisé,et al. Advanced imaging for detection and differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE) Guideline , 2014, Endoscopy.
[19] T. Karlsen,et al. Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis , 2014, Alimentary pharmacology & therapeutics.
[20] F. Carrat,et al. AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Radiologic Course of Primary Sclerosing Cholangitis: Assessment by Three-Dimensional Magnetic Resonance Cholangiography and Predictive Features of Progression , 2013 .
[21] A. Amiot,et al. European evidence based consensus for endoscopy in inflammatory bowel disease. , 2013, Journal of Crohn's & colitis.
[22] B. Gridelli,et al. Diagnosis of sclerosing cholangitis in children: blinded, comparative study of magnetic resonance versus endoscopic cholangiography. , 2013, Clinics and research in hepatology and gastroenterology.
[23] P. Schirmacher,et al. FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis. , 2013, Journal of hepatology.
[24] F. Vleggaar,et al. Population‐based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis , 2013, Hepatology.
[25] G. Gores,et al. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. , 2013, Gastroenterology.
[26] Elhamy K Bekhit,et al. Paediatric MRCP: 10 year experience with 195 patients. , 2013, European journal of radiology.
[27] U. Navaneethan,et al. Increased Serum Levels of Carbohydrate Antigen 19-9 and Outcomes in Primary Sclerosing Cholangitis Patients Without Cholangiocarcinoma , 2013, Digestive Diseases and Sciences.
[28] M. Miyazaki,et al. Comparison of the diagnostic accuracy of peroral video-cholangioscopic visual findings and cholangioscopy-guided forceps biopsy findings for indeterminate biliary lesions: a prospective study. , 2013, Gastrointestinal endoscopy.
[29] P. Moayyedi,et al. Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. , 2012, The Cochrane database of systematic reviews.
[30] C. Ponsioen,et al. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease , 2012, Inflammatory bowel diseases.
[31] M. Färkkilä,et al. Risk factors for complications of ERCP in primary sclerosing cholangitis , 2012, Endoscopy.
[32] S. Pereira,et al. Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience , 2012, European journal of gastroenterology & hepatology.
[33] T. Luedde,et al. Endoscopic ultrasound as an early diagnostic tool for primary sclerosing cholangitis: a prospective pilot study , 2012, Endoscopy.
[34] M. Färkkilä,et al. Biliary dysplasia in patients with primary sclerosing cholangitis: additional value of DNA ploidity , 2012, Liver international : official journal of the International Association for the Study of the Liver.
[35] H. Mulcahy,et al. Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[36] K. Boberg,et al. Inflammatory bowel disease in patients with primary sclerosing cholangitis: Clinical characterization in liver transplanted and nontransplanted patients , 2012, Inflammatory bowel diseases.
[37] G Costamagna,et al. Biliary stenting: Indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline , 2012, Endoscopy.
[38] G. Gores,et al. Cancer surveillance in patients with primary sclerosing cholangitis , 2011, Hepatology.
[39] N. Takahashi,et al. Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[40] E. Björnsson,et al. Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population‐based cohort , 2011, Liver international : official journal of the International Association for the Study of the Liver.
[41] A. Alkhatib,et al. Comorbidities, Sphincterotomy, and Balloon Dilation Predict Post-ERCP Adverse Events in PSC Patients: Operator Experience Is Protective , 2011, Digestive Diseases and Sciences.
[42] W. Kim,et al. Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[43] P. D. Renfrew,et al. Analytical review of diagnosis and treatment strategies for dominant bile duct strictures in patients with primary sclerosing cholangitis. , 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[44] M. Brand,et al. Antibiotic prophylaxis for patients undergoing elective endoscopic retrograde cholangiopancreatography. , 2010, The Cochrane database of systematic reviews.
[45] M. Dave,et al. Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography. , 2010, Radiology.
[46] M. Manns,et al. Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. , 2010, Gastrointestinal endoscopy.
[47] K. Boberg,et al. Validation of a cholangiographic prognostic model in primary sclerosing cholangitis , 2010, Endoscopy.
[48] D. Gotthardt,et al. Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment. , 2010, Gastrointestinal endoscopy.
[49] G. Gores,et al. Diagnosis and management of primary sclerosing cholangitis , 2010, Hepatology.
[50] M. Asaka,et al. Endoscopic retrograde cholangiography versus peroral cholangioscopy to evaluate intraepithelial tumor spread in biliary cancer , 2009, Endoscopy.
[51] Joseph Romagnuolo,et al. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. , 2009, Gastrointestinal endoscopy.
[52] M. Petrovecki,et al. Endoscopic ultrasound elastography as a method for screening the patients with suspected primary sclerosing cholangitis , 2009, European journal of gastroenterology & hepatology.
[53] B. Petersen,et al. Complications of Endoscopic Retrograde Cholangiopancreatography in Primary Sclerosing Cholangitis , 2009, The American Journal of Gastroenterology.
[54] K. Lindor,et al. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis , 2008, Hepatology.
[55] R. Kozarek,et al. A Twenty-year Experience With Endoscopic Therapy for Symptomatic Primary Sclerosing Cholangitis , 2008, Journal of clinical gastroenterology.
[56] N. Soehendra,et al. Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis , 2008, Endoscopy.
[57] B. Petersen,et al. Prospective Evaluation of Advanced Molecular Markers and Imaging Techniques in Patients With Indeterminate Bile Duct Strictures , 2008, The American Journal of Gastroenterology.
[58] M. Rutter. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? , 2008, Gastrointestinal endoscopy.
[59] D. Hommes,et al. More right‐sided IBD‐associated colorectal cancer in patients with primary sclerosing cholangitis , 2008, Inflammatory bowel diseases.
[60] M. Kimmey,et al. Complications after ERCP in patients with primary sclerosing cholangitis. , 2008, Gastrointestinal endoscopy.
[61] Angelo Andriulli,et al. Incidence Rates of Post-ERCP Complications: A Systematic Survey of Prospective Studies , 2007, The American Journal of Gastroenterology.
[62] D. Rubin,et al. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? , 2007, Gastrointestinal endoscopy.
[63] Steven C Cunningham,et al. Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution , 2007, Annals of surgery.
[64] A. Barkun,et al. The roles of magnetic resonance and endoscopic retrograde cholangiopancreatography (MRCP and ERCP) in the diagnosis of patients with suspected sclerosing cholangitis: a cost-effectiveness analysis. , 2007, Endoscopy.
[65] M. Trauner,et al. MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes. , 2007, Seminars in liver disease.
[66] E. Heathcote,et al. Sclerosing cholangitis: A focus on secondary causes , 2006, Hepatology.
[67] G. Gores,et al. Advances in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[68] K. Boberg,et al. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. , 2006, Journal of hepatology.
[69] G. Gores,et al. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. , 2006, Gastroenterology.
[70] K. Boberg,et al. Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[71] A. Maitra,et al. Utility of Bile Duct Brushings for the Early Detection of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis , 2006, Journal of clinical gastroenterology.
[72] K. Saeian,et al. Primary sclerosing cholangitis treated by endoscopic biliary dilation: Review and long-term follow-up evaluation , 2006, Current gastroenterology reports.
[73] C. Vu,et al. Duodenal EUS to identify thickening of the extrahepatic biliary tree wall in primary sclerosing cholangitis. , 2006, Gastrointestinal endoscopy.
[74] A. Bergquist,et al. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. , 2006, Seminars in liver disease.
[75] G. Gores,et al. The Value of Serum CA 19-9 in Predicting Cholangiocarcinomas in Patients with Primary Sclerosing Cholangitis , 2005, Digestive Diseases and Sciences.
[76] S. N. Agoff,et al. Biliary brush cytology and the detection of cholangiocarcinoma in primary sclerosing cholangitis: evaluation of specific cytomorphologic features and CA19-9 levels. , 2005, American journal of clinical pathology.
[77] T. Tsuyuguchi,et al. Diagnostic utility of peroral cholangioscopy for various bile-duct lesions. , 2005, Gastrointestinal endoscopy.
[78] S. N. Agoff,et al. Biliary Brush Cytology and the Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis , 2005 .
[79] L. Lawler,et al. Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography. , 2005, Gastrointestinal endoscopy.
[80] G. Guyatt,et al. Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches The GRADE Working Group , 2004, BMC health services research.
[81] A. Zinsmeister,et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis , 2004, Gut.
[82] A. Forbes,et al. Most dysplasia in ulcerative colitis is visible at colonoscopy. , 2004, Gastrointestinal endoscopy.
[83] B. Petersen,et al. Cost‐minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis , 2004, Hepatology.
[84] J Chilcott,et al. A systematic review and economic evaluation of magnetic resonance cholangiopancreatography compared with diagnostic endoscopic retrograde cholangiopancreatography. , 2004, Health technology assessment.
[85] E. Björnsson,et al. Dominant Strictures in Patients with Primary Sclerosing Cholangitis , 2004, American Journal of Gastroenterology.
[86] J M Grimshaw,et al. Effectiveness and efficiency of guideline dissemination and implementation strategies , 2004, International Journal of Technology Assessment in Health Care.
[87] R. Nayar,et al. Role of Biliary Brush Cytology in Primary Sclerosing Cholangitis , 2004, Acta Cytologica.
[88] D. Forman,et al. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia , 2003, Gut.
[89] J. Neuberger,et al. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis , 2003, Transplantation.
[90] R. Enns,et al. Predictors of successful clinical and laboratory outcomes in patients with primary sclerosing cholangitis undergoing endoscopic retrograde cholangiopancreatography. , 2003, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[91] A. Bergquist,et al. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. , 2002, Endoscopy.
[92] J. Reitsma,et al. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population , 2002, Gut.
[93] P. Heidenreich,et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. , 2002, Gastrointestinal endoscopy.
[94] W. Silverman,et al. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. , 2002, Gastrointestinal endoscopy.
[95] C. Rubio,et al. Low-Grade Dysplasia in Extensive, Long-Standing Inflammatory Bowel Disease , 2002, Diseases of the colon and rectum.
[96] S. Kakar,et al. The fate of low grade dysplasia in ulcerative colitis , 2002, American Journal of Gastroenterology.
[97] P. Sauer,et al. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. , 2002, Journal of hepatology.
[98] K. Boberg,et al. Cholangiocarcinoma in Primary Sclerosing Cholangitis: Risk Factors and Clinical Presentation , 2002, Scandinavian journal of gastroenterology.
[99] S. Linder,et al. Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer. , 2001, Hepato-gastroenterology.
[100] N. Chalasani,et al. Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis. , 2001, Gastrointestinal endoscopy.
[101] H. V. van Buuren,et al. Prospective Risk Assessment of Endoscopic Retrograde Cholangiography in Patients with Primary Sclerosing Cholangitis , 2000, Endoscopy.
[102] C. Benz,et al. [Primary sclerosing cholangitis]. , 2000, Der Internist.
[103] B. Petersen,et al. Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis , 2000, American Journal of Gastroenterology.
[104] A. Stiehl,et al. Value of Brush Border Cytology for Dominant Strictures in Primary Sclerosing Cholangitis , 1999, Endoscopy.
[105] G. Tytgat,et al. Value of brush cytology for dominant strictures in primary sclerosing cholangitis , 1998, Endoscopy.
[106] K. Lillemoe,et al. Primary sclerosing cholangitis: resect, dilate, or transplant? , 1998, Annals of surgery.
[107] G. Tytgat,et al. Lack of complications following short-term stent therapy for extrahepatic bile duct strictures in primary sclerosing cholangitis. , 1997, Gastrointestinal endoscopy.
[108] W. Stremmel,et al. Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study. , 1997, Journal of hepatology.
[109] M. Manns,et al. Endoscopic management of biliary tract strictures in primary sclerosing cholangitis. , 1996, Endoscopy.
[110] R. Löfberg,et al. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis , 1995, Diseases of the colon and rectum.
[111] L. Eriksson,et al. Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential , 1995, Hepatology.
[112] G. Tytgat,et al. Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis. , 1995, Gastrointestinal endoscopy.
[113] P. Cotton,et al. Endoscopic therapy of sclerosing cholangitis , 1995, Hepatology.
[114] C. Williams,et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. , 1994, Gastroenterology.
[115] H. Waldum. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. , 1992, Journal of hepatology.
[116] G. Lindberg,et al. Primary sclerosing cholangitis in ulcerative colitis--a risk factor for the development of dysplasia and DNA aneuploidy? , 1992, Gastroenterology.
[117] T. Sauerbruch,et al. Deterioration of cholestasis after endoscopic retrograde cholangiography in advanced primary sclerosing cholangitis. , 1992, Journal of hepatology.
[118] P. Grambsch,et al. Primary sclerosing cholangitis: value of cholangiography in determining the prognosis. , 1991, AJR. American journal of roentgenology.
[119] Roger M. Williams,et al. Improving biliary-enteric drainage in primary sclerosing cholangitis: experience with endoscopic methods. , 1991, Gut.
[120] C. Majoie,et al. Primary sclerosing cholangitis: a modified classification of cholangiographic findings. , 1991, AJR. American journal of roentgenology.
[121] P. Cotton,et al. Endoscopic and Radiologic Approaches to Therapy in Primary Sclerosing Cholangitis , 1991, Seminars in liver disease.
[122] E. Schrumpf,et al. Relationship of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis , 1991, Seminars in liver disease.
[123] D. Ransohoff,et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.
[124] R. Loe,et al. SCLEROSING CHOLANGITIS; REVIEW OF RECENT CASE REPORTS AND ASSOCIATED DISEASES AND FOUR NEW CASES. , 1965, American journal of surgery.
[125] Amy Wang,et al. Antibiotic prophylaxis for GI endoscopy. , 2015, Gastrointestinal endoscopy.
[126] U. Navaneethan,et al. Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis. , 2015, Gastrointestinal endoscopy.
[127] M. Picco. Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease , 2011 .
[128] F. Lammert,et al. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. , 2009, Journal of hepatology.
[129] Michelle A. Anderson,et al. Antibiotic prophylaxis for GI endoscopy. , 2008, Gastrointestinal endoscopy.
[130] P. Mccormick,et al. Diagnosing cholangiocarcinoma in primary sclerosing cholangitis: an “evidence based radiology” review , 2007, Abdominal Imaging.
[131] H. Goldberg,et al. Sclerosing cholangitis: Broad spectrum of radiographic features , 2005, Gastrointestinal Radiology.
[132] C. Ponsioen,et al. Four years experience with short term stenting in primary sclerosing cholangitis , 1999, American Journal of Gastroenterology.
[133] W. Hogan,et al. Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: a larger series and recommendations for treatment. , 1991, Gastrointestinal endoscopy.